BAP-1 in the diagnosis of malignant pleural mesothelioma

April 8, 2026 | Comments Off on BAP-1 in the diagnosis of malignant pleural mesothelioma

Respiratory Medicine and Research 2025 November 28 [Link] Irene Sansano, Ana Vázquez, Oscar Persiva, Marc Simó, Leire Sánchez, Pilar Montoya, Carme Dinarès, Carmen Alemán Abstract Background: The diagnosis of malignant…

Validation of chemoresistance phenotypes in pleural mesothelioma across 2D, 3D, and in vivo models

April 7, 2026 | Comments Off on Validation of chemoresistance phenotypes in pleural mesothelioma across 2D, 3D, and in vivo models

Scientific Reports 2026 February 11 [Link] Huaikai Shi, Sakthi Priya Selvamani, Richard Zelei, Ling Zhuang, Dongwei Wang, Ben Johnson, Vivek Dharwal, Duo Xu, Yiwei Wang, Tristan Rutland, Sonja Klebe, Steven…

Feasibility of multimodality treatment, including pleurectomy decortication, in carefully selected patients with sarcomatoid mesothelioma

April 6, 2026 | Comments Off on Feasibility of multimodality treatment, including pleurectomy decortication, in carefully selected patients with sarcomatoid mesothelioma

Translational Lung Cancer Research 202t6 January 31 [Link] Moshe Lapidot, Emanuele Mazzola, Raphael Bueno Abstract Background: Pleural mesothelioma (PM) represents an uncommon and exceptionally lethal malignancy. The sarcomatoid subtype constitutes…

Construction and validation of a prognostic risk score model for malignant mesothelioma

April 3, 2026 | Comments Off on Construction and validation of a prognostic risk score model for malignant mesothelioma

Discover Oncology 2026 February 8 [Link] Qingzheng An, Fengyun Cui, Guangming Shi, Longkun Ni, Kun Xiao, Feng Tian, Yuezhi Chen, Leping Li, Changqing Jing, Guodong Lian Abstract Purpose: Malignant mesothelioma…

The specificity of HEG1 as mesothelioma marker depends on the differential diagnosis

April 2, 2026 | Comments Off on The specificity of HEG1 as mesothelioma marker depends on the differential diagnosis

Virchows Archiv 2026 March [Link] Ben Davidson, Lara Maria Stričak, Arild Holth, Annette Torgunrud, Jeremias Wohlschlaeger, Martin Tötsch , Assia Bassarova Abstract The objective of this study was to analyze…

Disaster on MARS2? Lessons Learned from Modern Day Outcomes of Surgery for Pleural Mesothelioma

April 1, 2026 | Comments Off on Disaster on MARS2? Lessons Learned from Modern Day Outcomes of Surgery for Pleural Mesothelioma

The Annals of Thoracic Surgery 2026 February 2 [Link] Shubham Gulati, Andrea Wolf, Jai Mehrotra-Varma, Stephanie Tuminello, Emanuela Taioli, Raja Flores Abstract Background: The Mesothelioma and Radical Surgery 2 (MARS2)…

Neoadjuvant Pressurized Intraperitoneal Aerosol Chemotherapy for Conversion to Cytoreductive Surgery in Unresectable Malignant Peritoneal Mesothelioma: A Report of 2 Cases

March 31, 2026 | Comments Off on Neoadjuvant Pressurized Intraperitoneal Aerosol Chemotherapy for Conversion to Cytoreductive Surgery in Unresectable Malignant Peritoneal Mesothelioma: A Report of 2 Cases

The American Journal of Case Reports 2026 February [Link] Arnaldo Urbano-Ruiz, Bruna Latronico Palma, Ronaldo Elias Carnut Rego, Daniel Bianqui Guaraldo da Silva, Bianca Fava, Erlan Araujo Falcão , Michelle…

Adverse Renal Outcomes in Patients With Mesothelioma-A Territory-Wide Real-World Data

March 30, 2026 | Comments Off on Adverse Renal Outcomes in Patients With Mesothelioma-A Territory-Wide Real-World Data

Cancer Medicine 2026 February [Link] Wang Chun Kwok, James Chung Man Ho, Isaac Sze Him Leung, Desmond Yat Hin Yap Abstract Introduction: Advances in mesothelioma management have translated into longer…

Clinical applications of cryobiopsy in the diagnosis of thoracic malignancies: a comprehensive review

March 27, 2026 | Comments Off on Clinical applications of cryobiopsy in the diagnosis of thoracic malignancies: a comprehensive review

Japanese Journal of Clinical Oncology 2026 January 30 [Link] Miwa Kamatani, Nobuyasu Awano, Takehiro Izumo Abstract Accurate histopathological and molecular characterization of lung cancer is essential for optimal treatment selection…

Treatment Patterns, Clinical Outcomes, Health Care Resource Use, and Costs in Older Adults with Malignant Pleural Mesothelioma in the United States, 2007-2020

March 26, 2026 | Comments Off on Treatment Patterns, Clinical Outcomes, Health Care Resource Use, and Costs in Older Adults with Malignant Pleural Mesothelioma in the United States, 2007-2020

Advances in Therapy 2026 March [Link] Himani Aggarwal, Ashwini Arunachalam, Jae Min, Yu-Han Kao, Haidong Feng, Danmeng Huang, Gloria Odonkor Abstract Introduction: Malignant pleural mesothelioma (MPM) is a rare malignancy…

Categories